Father of 5 found dead in Ceres canal ID'd by Stanislaus County coroner
Authorities have identified the man who was found dead Sunday evening in an irrigation canal off Moore Road in Ceres, though questions remain about how he ended up in the water.
Luis Anguiano Calzado, 36, was confirmed as the deceased man by the Stanislaus County Coroner's Office, according to an email Tuesday from Lt. Jeffrey Godfrey of the Ceres Police Department. His cause of death is currently listed as undetermined, pending the results of toxicology testing.
First responders from the Ceres Fire Department, American Medical Response and Ceres Police were dispatched to the 3000 block of Moore Road just after 6 p.m. June 1 after reports of a possible drowning. Upon arrival, officials located Anguiano Calzado in the canal and pronounced him dead at the scene.
At this time, investigators say there is no evidence or witness statement indicating how Anguiano Calzado entered the canal. Police did not immediately release further details about his circumstances or whether foul play is suspected.
The case remains under investigation. Anyone with information is encouraged to contact the Ceres Police Department.
A GoFundMe page titled 'In Loving Memory of Luis Armando Anguiano Funeral Fundraiser' says he is survived by five children.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
30 minutes ago
- CBS News
Vandals cause "substantial" damage to Butler County golf course greens
Suspected vandals could face felony charges after causing significant damage to the Lake Arthur Golf Club in Butler County. "Somebody poured some type of substance onto several greens that caused a substantial amount of damage," said Pennsylvania State Police Trooper Bertha Cazy. The brown dead spots on the putting surface stick out like a sore thumb. "We're thinking it has something to do with some type of vinegar substance, something acidic that would cause damage to the greens," Cazy said. (Photo: KDKA) Investigators said five of the course holes were damaged and fixing them won't be cheap. "No, this is going to be up into the several thousands for them to repair," Cazy said. Course owners declined to comment on the situation, and the links were open on Friday. Meanwhile, investigators are looking for those responsible. "It could be kids or a disgruntled customer, we're really not sure, we don't really have any suspects at this time," Cazy said. "So we are asking for the public's help, if anyone knows anything or heard anyone talking about doing that damage, please let us know," Cazy said. Once apprehended, Cazy said those who defaced the greens could face a lot more than a slap on the wrist. "Depending on how much money it's going to cost to repair that, and it's going to be in the several thousands, which would be at least a third-degree felony," Cazy said.
CBS News
37 minutes ago
- CBS News
Who's responsible for cracked streetlights leaning over a Boston road?
The I-Team is getting the bottom of a potentially dangerous problem in a Boston neighborhood. Ann Marie Ford lives in Dorchester and says she's concerned about the streetlights along Gallivan Boulevard. Many look to be in in disrepair, and she says they could pose a danger. Ann Marie pointed out the cracks, rust and crumbling concrete telling the I-Team, "I was kind of shocked, because we just saw the one and then when we looked up, we saw them all down the median and it's dangerous." "Someone could get killed" Potentially dangerous because the light poles are leaning into the street. We brought in Wentworth Institute of Technology Engineering Professor James Lambrechts who explained the danger. "Someone could get killed," Lambrechts said. Streetlight leaning on Gallivan Blvd. in Boston. CBS Boston Lambrechts says it's clear the poles are leaning towards the highway. "As it leans more, it bends more," Lambrechts said. "Its foundation is going to be overloaded. That's not good." Lambrechts found the poles are not just leaning, but cracking. "These are not good things for the pole to have this problem and it shouldn't be like this," Lambrechts said. Who owns the streetlights? Gallivan Boulevard is a state DOT road. The I-Team asked for the inspection reports for the streetlights. DOT told us DCR owns the road. It does not. State records show Gallivan Boulevard was transferred to DOT in 2009. DOT then said Eversource owns the poles and told us it has notified the utility company about possible safety or maintenance issues. But they could not tell us when the poles were last inspected or whether the repairs or maintenance had been done. "You got to come out and maintain these things every once in a while," Lambrechts said. "They all need to be inspected, evaluated and replaced as necessary." Eversource has received calls about streetlights As for Eversource, it refused to provide the I-Team with any records, but released a statement: "Delivering safe, reliable energy service to our customers is always our top priority, and we are constantly working to maintain and upgrade our local electric distribution system across Massachusetts. With respect to the streetlights on Gallivan Boulevard, our maintenance responsibilities currently include maintenance of the pole, cable and luminaire. We also inspect these streetlights annually for stray voltage, and if we record an elevated voltage reading or other issue on a Gallivan Boulevard streetlight structure, we provide those findings and locations to the commonwealth. Our troubleshooters - who are out in our communities 24/7 - are also constantly evaluating the condition of infrastructure, including streetlights, as part of their daily work. If our crews observe that a pole's condition poses a safety risk to the public, we work as quickly as possible to address that risk with the appropriate repairs, including replacements when needed. It is important to note that there are different considerations for concrete streetlight poles compared to a wooden utility pole, and if a concrete streetlight pole may have a lean, or visible crack, it doesn't necessarily pose a risk to public safety. Gallivan Boulevard is a highly traversed state roadway with motor vehicle accidents that can cause such damage. Our customer call center has received a handful of calls about streetlights on Gallivan Boulevard this year, and any reports made to our call center about streetlight conditions get assigned for additional inspection. The City of Boston and our state agencies also have dedicated account representatives who communicate with those entities on a daily basis, and we have not received any separate recent complaints regarding streetlights on Gallivan Boulevard from state agencies or the city. When we do receive complaints, we have a process in place to coordinate with MassDOT and the City of Boston to quickly address any potential safety or reliability issues. Any decision to make a repair or to replace a pole is prioritized solely by safety and reliability." Problem light poles in Boston Lambrechts says it's their responsibility to maintain the poles. "If it falls over it's not safe," Lambrechts said. The risk of light poles in poor condition falling is real. In September of 2022, a woman was seriously injured when a corroded streetlight fell on the Moakley Bridge in Boston. An I-Team investigation found the city knew about the problem as far back as 2017. WBZ also uncovered a state report from months earlier showing the poles required immediate repair, but nothing was done. After the incident the city removed nearly two dozen dangerous poles. As for the streetlights on Gallivan Boulevard, Lambrechts says maybe there is a protocol to change these out, but if not, he says he would not drive on the roadway in a storm. Just weeks ago, DOT started a new program requiring inspections and the keeping of records for structures along their roadways, regardless of who owns them.
Yahoo
41 minutes ago
- Yahoo
Incyte replaces CEO Hoppenot with dealmaker Meury
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Incyte has named veteran pharmaceutical executive Bill Meury as its new CEO, replacing longtime head Hervé Hoppenot, who led the cancer and blood disease drugmaker for the past 11 years. Meury, whose appointment is effective immediately, previously ran Anthos Therapeutics, which he sold this year to Novartis for nearly $1 billion, and Karuna Therapeutics, which Bristol Myers Squibb bought for $14 billion in 2023. Prior to those posts, Meury was chief commercial officer at Allergan. Hoppenot will remain on Incyte's board of directors through the end of this year to aid Meury's transition into the CEO role. Alongside the succession, Julian Baker, managing partner of biotechnology investor Baker Bros. Advisors and lead independent director for Incyte, was elected board chair. Much of Hoppenot's time at Incyte focused on what he once described as 'single asset syndrome.' The company has had a good deal of success with Jakafi, a multipurpose drug approved to treat rare blood cancers and graft-versus-host disease. Last year, Jakafi brought in nearly $2.8 billion in sales. But Jakafi's main patents expire in 2028, a date that for years now has been on investors' radar as they've pressed Incyte on what it expects will take the drug's place. Early in Hoppenot's tenure, the answer looked like a cancer medicine called epacadostat, which Incyte believed could become a cornerstone of immunotherapy combinations. However, it flamed out in testing in 2018 and Incyte was forced to pivot research toward other candidates. Since then, Incyte has had some success building out its portfolio. The company now owns six other approved drugs, including a cream formulation of Jakafi's main ingredient that's proved useful treating atopic dermatitis and vitiligo. 'Hervé joined Incyte in 2014 when it was a single product, U.S.-only company,' said board member Baker, in a statement. 'During Hervé's tenure, Incyte launched six novel medicines plus two new indications for Jakafi, expanded commercial operations into Europe, Japan and Canada and grew revenues from $355 million dollars in 2013 to $4.2 billion today.' However, Incyte's other drugs don't make it much money. Jakafi and the cream formulation of the drug Incyte sells as Opzelura accounted for 91% of net product revenues last year. (The company also earned nearly $600 million in royalty revenues.) Stephen Willey, an analyst at Stifel, gives Hoppenot credit for increasing Incyte revenues by more than 10 times during his time as CEO. But, in a Thursday note to clients, he added that some investors grew frustrated with the company's high research and development spending without a clear post-Jakafi plan. Shaping those plans will now fall to Meury, who gained industry visibility by guiding his prior two companies to lucrative acquisitions. 'We expect the immediate reaction from investors will be an expectation that [Incyte] could now become an M&A target, simply because Mr. Meury sold Anthos ... and sold [Karuna],' wrote RBC Capital Markets analyst Brian Abrahams, in a note to clients. Shares in Incyte, which have fallen by 30% over the past five years, rose by more than 4% in Thursday morning trading on the CEO news. 'It has been a privilege to lead Incyte over the past eleven years,' Hoppenot said in the company's statement. 'I am proud to retire at a time when Incyte has the strongest management team, internal R&D pipeline and commercial portfolio ever.' Incyte expects multiple pivotal trial readouts this year, along with proof-of-concept data for several pipeline candidates. Recommended Reading Unblinded: Hervé Hoppenot on solving Incyte's 'single asset syndrome' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
